These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Emphysematous cystitis with concomitant bilateral emphysematous ureteritis and pyelitis in a diabetic patient. Hajji F; Ameur A Pan Afr Med J; 2015; 20():324. PubMed ID: 26175815 [No Abstract] [Full Text] [Related]
24. A comparison of single plasma sample methods to estimate renal clearance using 99mTc-ethylenedicysteine and 99mTc-mercaptoacetyltriglycine. Sohaib M; Rafique A; Saeed S; Afshan A Clin Physiol Funct Imaging; 2013 Sep; 33(5):353-8. PubMed ID: 23701132 [TBL] [Abstract][Full Text] [Related]
25. Emphysematous pyelitis: epidemiological, therapeutic and evolutive features. Derouiche A; El Attat R; Hentati H; Blah M; Slama A; Chebil M Tunis Med; 2009 Mar; 87(3):180-3. PubMed ID: 19537009 [TBL] [Abstract][Full Text] [Related]
26. 67Ga SPECT/CT of infected bladder stones and pyelitis. Lee M; Lee JS; Baek JH; Hyun IY Clin Nucl Med; 2015 Mar; 40(3):244-6. PubMed ID: 25546213 [TBL] [Abstract][Full Text] [Related]
27. Prospective validation of single plasma sample 99mTc-ethylenedicysteine clearance in adults. Kabasakal L; Halaç M; Yapar AF; Alkan E; Kanmaz B; Onsel C; Sönmezoğlu K; Ayaz M; Kalender B; Sayman HB; Uslu I J Nucl Med; 1999 Mar; 40(3):429-31. PubMed ID: 10086707 [TBL] [Abstract][Full Text] [Related]
29. Emphysematous Pyelitis: An Entity Distinct from Emphysematous Pyelonephritis. Maiti A; Saha D; Das A Am J Med Sci; 2017 May; 353(5):505. PubMed ID: 28502342 [No Abstract] [Full Text] [Related]
30. Urinary tract infection and other pediatric considerations. Rossleigh MA Q J Nucl Med; 2002 Dec; 46(4):304-10. PubMed ID: 12411870 [TBL] [Abstract][Full Text] [Related]
31. Captopril renography. Considerations in the selection of radiopharmaceuticals, provocative agents, and hypertensive subjects. Blaufox MD Am J Hypertens; 1991 Dec; 4(12 Pt 2):675S-677S. PubMed ID: 1777182 [TBL] [Abstract][Full Text] [Related]
37. Two urinomas after a renal allograft demonstrated by hybrid SPET-CT. Balasubramanian HC; Mittal BR; Bhattacharya A; Singh B; Minz M Hell J Nucl Med; 2008; 11(3):184. PubMed ID: 19081867 [No Abstract] [Full Text] [Related]
38. [Emphysematous pyelitis and pyelonephritis: unrecognized clinical entities]. Mainil-Varlet P; Deger F; Dekoninck WJ; Vanhaeverbeek M Rev Med Brux; 1990 Sep; 11(7):251-6, 259. PubMed ID: 2218205 [TBL] [Abstract][Full Text] [Related]
39. Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals. Verbruggen AM; Nosco DL; Van Nerom CG; Bormans GM; Adriaens PJ; De Roo MJ J Nucl Med; 1992 Apr; 33(4):551-7. PubMed ID: 1532419 [TBL] [Abstract][Full Text] [Related]
40. Preliminary assessment of interand intraobserver reproducibility, and normative values of renal mean transit time (MTT) and parenchymal transit time (PTT) for 99mTc-etylenodicysteine. Cichocki P; Surma M; Woźnicki W; Bieńkiewicz M; Płachcińska A; Kuśmierek J Nucl Med Rev Cent East Eur; 2015; 18(1):29-34. PubMed ID: 25633514 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]